Lakefront Biotherapeutics NV
LKFT
$27.43
-$0.20-0.72%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
9/9/2026
-
Tickeron - Stocks
9/8/2026
-
Globe Newswire
9/8/2026
-
Globe Newswire
9/5/2026
-
The Cerbat Gem
9/1/2026
-
TipRanks
9/1/2026
-
Globe Newswire
8/31/2026
-
TipRanks
8/25/2026
-
Globe Newswire
8/24/2026
-
TipRanks
8/24/2026
-
TipRanks: TheFly
8/24/2026
-
Globe Newswire
8/24/2026
-
Globe Newswire
8/21/2026
-
MarketBeat
8/20/2026
-
PR Newswire
8/19/2026
-
MarketBeat
8/18/2026
-
Globe Newswire
8/18/2026
-
The Cerbat Gem
8/13/2026
-
The Cerbat Gem
8/12/2026
-
TipRanks
8/12/2026
-
Globe Newswire
8/11/2026
-
MarketBeat
8/11/2026
-
TipRanks
8/11/2026
-
TipRanks: TheFly
8/11/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, August 12, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
32 1 534 29 00
Address
SchaliEnhoevedreef 20 T
Mechelen, 2800
Mechelen, 2800
Country
Year Founded
Business Description
Sector
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise...
more